Shares of Nuvalent rose after the company offered promising updates about the progress of its parallel lead cancer drug programs through clinical trials. The stock was up 20% at $105 in premarket ...
Israel has added a new objective to its ongoing war, turning its focus on the Lebanon border, as questions arise over the future of its defense minister’s position. The country’s security ...